1996P Primary analysis of post-marketing surveillance (PMS) data for avelumab maintenance therapy in patients (pts) with curatively unresectable urothelial carcinoma (UC) in Japan

Autor: Kikuchi, E., Nagata, M., Ito, T., Sato, M., Ogi, M., Morita, M., Kajita, M., Nishiyama, H.
Zdroj: In Annals of Oncology September 2024 35 Supplement 2:S1155-S1155
Databáze: ScienceDirect